Bloomberg Law
Jan. 21, 2021, 10:48 PM

Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March

Jacquie Lee
Jacquie Lee
Reporter

The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients.

Centers that don’t pass on the savings wouldn’t qualify for federal grants. The rule, which was finalized in late December, is delayed until March 22, the Department of Health and Human Services said in a Federal Register post.

This freeze is part of the Biden administration’s large-scale effort announced this week that will scrutinize the Trump administration’s health policies. If the previous administration’s policies raise “fact, law, or policy” concerns, the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.